TheProfitWatch

MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.59 0.01 (0.61%) --- -0.01 (-0.62%) 0.0 (0.0%) --- --- 0.01 (0.61%) 0.01 (0.61%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-17.7778
Diluted P/E:
-17.7778
RSI(14) 1m:
50.0
VWAP:
1.6
RVol:
0.0108

Events

Period Kind Movement Occurred At

Related News